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A C C E P T E D M
A N U S C R I P T Even before birth, sex differences in fetal growth and fetal and neonatal morbidity and mortality are well known (Vatten et al., 2004; Di Renzo et al., 2007; Engel et al., 2008) . Sex-biased health challenges later in life have also been linked with antepartum maternal risk factors in pregnancy, including severe chronic asthma, pre-eclampsia, and preterm delivery (Vatten et al., 2004; Clarke et al., 2007) . In addition, there is considerable evidence that antenatal stress influences sexspecific risk for a wide range of developmental and mental health challenges throughout the lifespan (Davis and Pfaff, 2014; Sandman et al., 2013; Gluckman et al., 2008) . It remains challenging, however, to identify developmental sex differences in the intra-uterine environment that might underlie the sex differences later in life (Stirrat and Reynolds, 2016) .
In 2013, we published results comparing cortisol and corticosterone concentrations in umbilical arterial serum (returning from the fetus towards the placental circulation) and umbilical venous serum (inbound from the placenta towards the fetus) for a sample of 265 healthy, fullterm deliveries (Wynne- Edwards et al., 2013) . That analysis showed that the fetus preferentially secreted corticosterone, rather than cortisol, in response to fetal stress during vaginal delivery versus scheduled, elective Caesarian deliveries.
Those scheduled Caesarian deliveries (N= 52, 27 male) were assumed to be representative of the full-term, third trimester, utero-placental environment, since neither mother nor baby had undergone the stress of antecedent labor, and regional spinal anesthetic, rather than general anesthesia, was used for all deliveries. A sex difference in the umbilical circulation was found with regards to cortisol, but not corticosterone (Giesbrecht et al., 2016) . Term pregnancies with a female fetus had higher cortisol in both venous and arterial serum than pregnancies with a male fetus. Both sexes added cortisol to umbilical circulation but there was no evidence that the proportional increase in cortisol across the fetus was different for the male and female fetus.
A N U S C R I P T Thus, the full-term female fetus was exposed to higher overall circulating cortisol concentrations than the male, suggesting that placental influences on umbilical cord cortisol concentrations differed by sex (Clifton, 2010) .
The current study had three objectives: First, to confirm the previously described sex difference in cortisol (Giesbrecht et al., 2016) , in an independent replicate sample of scheduled, elective, Caesarian births without antecedent labor. Second, to confirm preferential corticosterone synthesis by the fetus. Third, to broaden the number of adrenal and gonadal steroid biosynthesis steroids quantified to include substrates, and clearance products.
Specifically, steroids quantified were two substrates for cortisol,17-hydroxyprogesterone and 11-deoxycortisol, two immediate breakdown products of cortisol and corticosterone, cortisone and 11-dehydrocorticosterone, plus testosterone and its immediate precursor, androstenedione. This array was chosen to place the male-female difference in cortisol pool size and net cortisol addition into the context of its broader adrenal steroidogenesis pathway.
Material and Methods
In all respects, sample collection and handling methods constituted an experimental replication of an earlier cohort (Wynne- Edwards et al., 2013) . Additions to that method were the inclusion of multiple births and the inclusion of preterm births. A change in mass spectrometry steroid quantitation method is addressed in Section 1.7. Finally, the previous cohort had only cortisol and corticosterone quantified whereas the current steroid analysis method was expanded to include an additional four adrenal and two gonadal steroid hormones. Steroids quantified are highlighted in Figure 1 , in the context of their steroidogenic pathways, with the enzymes responsible for each conversion. In addition to cortisol and corticosterone, two cortisol precursor
steroids were quantified. 17-hydroxyprogesterone is a direct precursor of cortisol, through 21-hydroxylase conversion to 11-deoxycortisol, followed by mitochondrial 11ß-hydroxylase conversion to cortisol. Progesterone saturated the mass spectra and could not be quantified as the internal standard peak could not be diluted and retain precision. Deoxycorticosterone and aldosterone methods were not available. Initial clearance products, which are the result of 11ß-hydroxysteroid dehydrogenase (11ß-HSD) activity, yield cortisone and 11-dehydrocorticosterone. 11-dehydrocorticosterone is also the substrate for aldosterone synthesis.
Testosterone and its immediate precursor, androstenedione, were also quantified.
Ethics Statement
This research was granted ethics approval by the University of Calgary Conjoint Health
Research Ethics Board (CHREB) as Project E22197R2. Written consent, on a form approved by the CHREB, was obtained, witnessed, and a copy returned to the pregnant subject at the time of admission to the hospital. Consent addressed access to maternal labor and delivery chart records, and approval for umbilical cord blood sampling. No maternal blood was requested. No other access to the infant or maternal medical record was sought. Intra-partum chart data was coded by authors KL and HEE, the Obstetrician-Gynecologists who collected the samples. Hormone quantitation was blind to all chart data but samples were coded to pair arterial and venous umbilical cord samples within subjects.
Subject Pool
Between March 2014 and the end of January 2015, written consent was obtained from 328 pregnant subjects at the time of admission to labor and delivery at the Rockyview General Hospital or the Foothills Medical Centre in Calgary, AB. No attempt was made to assess ethnicity or socioeconomic status. Five exclusions were applied. One mother was under active
steroid treatment for Addison's disease, one infant had severe fetal acidosis, and three births had known collection errors. For the purposes of this analysis, all pre-term births (<37 weeks), and all term births with antecedent labor were excluded. This filter yielded 53 births (33 male). One set of full-term female twins at 37 weeks was treated as two independent subjects because they had separate placentae and membranes (dichorionic and diamnionic). The delivery record provided sex of the baby, birth weight, gestational age, maternal risk factors, and infant Apgar score 5 minutes after delivery as a measure of fetal condition at delivery.
Sample collection
There was no interference with normal post-partum protocol that routinely samples umbilical arterial and venous blood for pH and acid-base status. After that sampling, but prior to delivery of the placenta, one non-heparinized, 'red top', vial of umbilical venous and another of umbilical arterial whole blood were collected by needle aspiration (16 gauge). As per the initial study, 4.2% (or N=2) of arterial samples obtained by needle aspiration were expected to be contaminated with venous blood, based on a decrease, rather than increase, between arterial [A] and venous [V] cortisol concentration (Wynne- Edwards et al., 2013 ). In the current study, the sampling error is likely to be even lower. Looking only at males, all [A-V] changes for testosterone were positive, and the sole cortisol [A-V] that was slightly negative (-0.24 nmol/l) was in a subject with a strong testosterone increase (3.38 nmol/l). Samples were immediately refrigerated and allowed to stand for at least one hour before being centrifuged (4000 xG for 5 min). Serum was separated and stored at -20˚C until delivery to the research laboratory.
Sample preparation
Cortisol, cortisone, corticosterone, 11-deoxycortisol, 11-dehydrocorticosterone, testosterone, 17-hydroxyprogesterone, and androstenedione calibrators were purchased from Steraloids Inc were centrifuged at 4000 xG for 15 minutes and 90 µL of supernatant was submitted to analysis.
LC-ESI+/MRM acquisition method
Quantitation used an Agilent 1200 binary liquid chromatography (LC) system coupled to an AB SCIEX QTRAP 5500 tandem mass spectrometer equipped with an electrospray (ESI) ionization source in positive mode. LC separation was performed on an Agilent ZORBAX Eclipse plus C18 column (100 x 2.1 mm, 1.8 µm particle size) at 40˚C. Mobile phase A was ACN/H2O (5/95, v/v, 2mM NaF) and the mobile phase B was 100% ACN (2mM NaF). The 12 min gradient was 15-70% B (0-6 min), 70-100% B (6-7 min), 100% B (7-8.5 min), 100-15% B (8.5-9 min), held at 15% B for 3 min. Flow rate was 0.6 mL/min and injection volume was 15 µL. Acquisition parameters were: N2 curtain gas 45 psi, temperature 750˚C, ion source gas 1 18 psi, ion source gas 2 30 psi, collision gas medium, ionspray voltage 5000. Mass resolutions in Q1 and Q3 were set to unit resolution. 
Steroid Quantitation
Calibration curves (r2 > 0.0995) used analyte concentration (x axis) vs analyte/IS peak area ratios (y axis), and a linear fit with 1/x weighting to improve precision at lower concentrations.
Calibration curves (10 point) ranged from 0.1 ng/ml to 100 ng/ml for cortisol, corticosterone, cortisone and androstenedione. Other steroid calibrators ranged from 0.05 to 50 ng/ml. The lowest concentration that gave <20% CV was deemed the lower limit of quantification (LLOQ), which was 0.1 ng/ml for all steroids except cortisol, at 0.2 ng/ml. Four quality control (QC) pools in MeOH, matched to ultrahigh (25 or 12.5 ng/ml), high (5 or 2.5 ng/ml), mid (0.5 or 0.25 ng/ml) or low (0.1 or 0.05 ng/ml), plus a triplicate serum pool, were quantified within each of 4 runs.
Accuracy across all mid, high and ultrahigh QC from each of 8 steroids was 99.96% (range 88.0% -109.3%) with an average intra-run CV of 5.72%. Low QC were more variable across 8 steroids (average CV = 23.4%) but still accurate (95.88%, range 84.8% -108.0%). Serum pools delivered an average intra-run CV of 7.8% (across 8 steroids) and inter-run CV of 17.1% (max 22.6%). Paired venous and arterial samples were always in the same run.
Validation of quantitation method change
This study used a different steroid quantitation method than Wynne- Edwards et al. (2013) .
Therefore, a subset of 150 samples from the current dataset (75 matched pairs) were also quantified for cortisol and corticosterone using the APCI positive acquisition method of Wynne- Edwards et al. (2013) . The methods were well-correlated for both cortisol and corticosterone (cortisol r = 0.9633 with 95% non-parametric density range from 0.9306 and 0.9807, slope
0.8145, intercept 5.0975; corticosterone r = 0.9854 with 95% non-parametric density range between 0.9720 and 0.9923, slope 0.9917, intercept 0.1844). Thus, cortisol and corticosterone concentrations are comparable, although reported in different units (nmol/l rather than ng/ml).
Analytical parameters
Prior to statistical analyses, all quantitation results in ng/mL were converted to nmol/l because molar concentrations were essential to compare the molecular pools of substrate, product, and breakdown product steroids, as each steroid has a different molecular weight (i.e 1 ng contains fewer molecules as the molecular weight increases). Although the units differ, definitions of analytical parameters from Wynne-Edwards et al. (2013) However, interpretation of the concentration change on the materno-placental side of the umbilical circulation is challenging because neither steroid exchange with maternal circulation nor placental steroid pools were assessed (Wynne- Edwards et al., 2013; Giesbrecht et al., 2016) .
Statistical analyses
To assess molecular flows from substrates through to clearance products, concentrations (nmol/l) in arterial and venous samples were treated as matched pairs and change parameters [A-V] and
were calculated from untransformed concentrations. This quantitation method is linear throughout the calibration range (neither the x nor y axes are transformed before fitting the line).
Parametric approaches were used throughout analyses. Non-parametric approaches yielded the same conclusions. A parallel results section is available in supplemental materials with nonparametric equivalent statistical findings inserted (Supplemental 1). The cohort was homogenous with respect to gestational age, and the sample size was too small to partition by other demographic or intra-partum variables. All analyses were conducted using JMP version 13.1.0 (SAS Institute, North Carolina). For two sample male-female comparisons, t-tests are reported. A critical alpha threshold of 0.005 was applied to avoid type II errors due to multiple comparisons within each steroid (4 parameters, two sexes). One statistical replication of a sex effect on cortisol applied an alpha threshold of 0.05, to match the previous statistical approach and is noted in the results.
Results

Demographics
Within this full term (≥ 37 weeks) cohort of 53 births (TABLE 1) , there were 13 births (24.5%) with antepartum risk factors: three IUGR (intrauterine growth restriction at 10 th percentile),
LGA (large for gestational age at 90 th percentile), two diet-controlled gestational diabetes (+/-polyhydramnios), and one essential hypertension. Antepartum risk factors were summed to yield a risk profile score and did not differ by sex. All infants were healthy, with 51/53 babies having an Apgar score of 9/10 at five minutes after birth and the remaining two at Apgar 8. None of the infants were admitted to the Neonatal Intensive Care Unit. Male birthweight was significantly higher than female birthweight (TABLE 1) .
Gonadal steroids: androstenedione and testosterone
The two gonadal steroids, testosterone and androstenedione, accounted for less than 2% of the total molarity across all eight steroids quantified. As expected, the male fetus had higher concentrations of testosterone than females in both the venous (0.72 ± 0.07 nmol/l vs 0.14 ± androstenedione and testosterone concentrations were independent in males.
Male and Female Glucocorticoid Pathway Steroid Concentrations
In order of abundance in the venous circulation approaching the fetus, cortisone was at the highest concentration. Cortisol was the next most abundant steroid. In all cases, 17-hydroxyprogesterone was third in abundance, followed by the corticosterone analogue of cortisone, 11-dehydrocorticosterone, and then the precursor of cortisol, 11-deoxycortisol, and lastly, corticosterone.
Replicating the findings in Giesbrecht et al. (2016) , where a critical alpha of 0.05 was applied, cortisol concentrations in venous umbilical cord were higher with a full-term female The cumulative steroid complement for male and female, in venous and arterial serum, is shown in FIGURE 2. Total steroid molarity, summed across the six steroids, was not different for males and females in the arriving, venous, circulation (t(36.7) = 0.77, p = 0.447). However, there were sex differences in total molarity after the fetus, in arterial circulation (t(26.6)= 2.72, p = 0.011). The total nmol/l for venous serum arriving at the male fetus was not different from the paired arterial sample (-2.0 ± 13.0 nmol/l, paired t(32)= 0.15, p = 0.8785). In contrast, +65.2 ± 19.1 nmol/l were added by the female fetus (paired t(19)= 3.42, p = 0.0029). Thus, male total steroid molarity was stable whereas female total molarity increased.
Fetal steroid synthesis and clearance [A-V]
Widespread changes in the molarity of individual steroids were noted (FIGURE 3). Within each sex, steroid molarity changed from venous to arterial samples as the circulation crossed the fetus.
For males, net corticosterone and net cortisol synthesis was seen, while the substrates, 11-dehydrocorticosterone, cortisone, 11-deoxycortisol and 17-hydroxyprogesterone, were depleted/cleared. When the fetus was female, corticosterone and cortisol were also actively added by the female fetus. However, decreases in cortisone, 11-dehydrocorticosterone and 17-hydroxyprogesterone were not significantly different from zero.
Replicating the previous finding (Giesbrecht et al., 2016) , between-sex differences were seen for cortisol (male 39.0 ± 6.1, female 72.4 ± 13.1; t = 2.31, p = 0.029), but not corticosterone (male 6.78 ± 1.1, female 10.46 ± 6.78; t = 1.61, p = 0.12). Depletion of pools of the immediate
precursor of cortisol, 11-deoxycortisol, were not responsible for this between-sex difference ([A-V] males (-2.30 ± 0.38, females -0.90 ± 0.53; t = 2.14, p = 0.039). At the critical alpha of p < 0.005, cortisone depletion also did not differ between the sexes (males -29.9 ± 8.1; females 3.16 ± 10.0; t = 2.07, p = 0.045).
Preferential fetal corticosterone synthesis [A-V]/[V]
As found for the Giesbrecht et al. (2016) cohort, there was no difference in proportional increase in cortisol between the sexes (80 ± 13, 65 ± 12, p = 0.425). Thus, cortisol steroidogenesis was proportionately similar for female and male, but female umbilical circulation consisted of higher arriving, and even higher departing, cortisol concentrations than males. Proportional steroid concentration changes for the other steroids also did not differ by sex (TABLE 2) . As expected, the proportional change in corticosterone with the sexes pooled (290 ± 25) was significantly larger than the proportional change in cortisol (71 ± 9; Paired t(52) = 11.05, p < 0.0001). Fetal adrenal glucocorticoid synthesis at full-term was biased towards corticosterone.
Steroid correlations within individuals
As the synthesis (11ß-hydroxylase) and back-synthesis (11ß-HSD1) enzymes for cortisol and 
Discussion
Independent confirmation of previous findings
Recently, we described full-term sex differences in umbilical cord glucocorticoid concentrations (immediately after scheduled Caesarean delivery) in the human fetus (Giesbrecht et al., 2016) . In that study, females had higher concentrations of cortisol than males in both venous and arterial umbilical cord samples and added more cortisol than corticosterone. However, the proportionate increase ([A-V]/[V]) was similar. Without knowing whether substrates were at similar concentrations, that paper was unable to determine whether the combination of synthesis and clearance within the fetus was proportionate to the concentration of the substrate arriving in
venous circulation (Giesbrecht et al., 2016) . The current study replicated that study, collecting an independent set of matched arterial and venous umbilical cord samples at full-term (38.5 wks).
Again, females had higher concentrations of cortisol than males in both venous and arterial cord samples, and a larger absolute increase across the fetus, but a similar proportionate increase.
Thus, higher concentrations of cortisol in umbilical circulation when the fetus is female is confirmed.
Explicit paired comparison of venous and arterial samples was important to detecting this sex difference. Although Stark et al. (2009a) reported increased cortisol concentrations in neonatal female cord blood and urine at 24 h, relative to males, Clifton et al. (2007) found no sex difference in umbilical cord steroid profiles, using high-pressure liquid chromatography techniques on mixed cord blood from neonates at the time of elective Caesarean section. In human umbilical cord, venous circulation towards the fetus travels within a large, thin-walled vessel, whereas human umbilical arteries are smaller in diameter, and more thick-walled. Thus, arterial blood is a minor contributor to mixed cord blood sampling. A wide range of cortisol concentrations is typical of umbilical cord serum (Wynne- Edwards et al., 2013) . When stress of delivery is added to the delivery experience (spontaneous vaginal deliveries and FTP 2 emergency Caesarian sections as compared to these elective Caesarian sections) fetal sex differences in cortisol were not detectable (Wynne- Edwards et al., 2013) .
Wynne- Edwards et al., (2013) demonstrated that any fetus that had gone through stage 2 of labor (all vaginal deliveries plus emergency Caesarian sections for failure to progress in the second stage of labor (FTP2)) increased the preferential secretion of corticosterone, rather than cortisol. To aid in the interpretation of this finding, the current data set was specifically designed to yield a 'substrate to product' steroid snapshot of full-term umbilical circulation under the A C C E P T E D M A N U S C R I P T least-stressed fetal state possible. To achieve this, labor was excluded. During labor, maternal cortisol diffusing across the placental interface increases to the point of saturating the placental activity of 11ß-HSD2, allowing the excess cortisol to reach the fetus (Chapman et al., 2013) .
These elective scheduled Caesarian sections, in contrast, were conducted under regional spinal anesthetic, avoiding widespread physiological responses. Normal maternal anticipatory anxiety and excitement were expected to increase cortisol, but to be converted to cortisone by abundant placental 11ß-HSD2 before reaching umbilical venous circulation (Chapman et al., 2013; Stirrat et al., 2018) , and were not expected to influence the umbilical steroid environment. Thus, the steroid concentrations and changes reported here were assumed to be representative of a 'baseline' full-term state, as opposed to the more stress-filled situation, for mother and baby, in vaginal deliveries with head compressions during stage 2 of labor.
Preferential corticosterone synthesis in both sexes
Nevertheless, despite the relative lack of stress in these elective Caesarian deliveries, preferential corticosterone secretion was clear, and confirms the finding in Giesbrecht et al., (2016) . Sex differences in steroid pools and biosynthetic activity are known. For example, within the current data, we would expect male fetal 17ß-hydroxysteroid dehydrogenase enzyme activity in the testes to add testosterone, as seen. We would also expect female testosterone synthesis to be lower because females have no testes.
In contrast to testosterone, none of the quantified steroids in the adrenal steroid pathway showed sex differences in proportionate change, whether it was a depletion or an addition. This supports the null hypothesis that neither adrenal steroidogenic pathway enzymes, nor tissue distributions of those enzymes, differ between the sexes. It also suggests that the corticosteroid binding capacity of umbilical serum is not different between males and females. Corticosteroid
binding was expected (Jeffray et al., 1999; Edwards and Boonstra, 2017) , but not assessed.
Failure to reject that null hypothesis suggests that preferential corticosterone synthesis is achieved through competitive, differential, enzyme-substrate affinity. Alterations in the action of 17-alpha hydroxylase, which converts progesterone to 17-hydroxyprogesterone, largely determine whether the adrenal synthesis pathway leads to corticosterone or cortisol. If substrate pool size was responsible for the observed, higher, concentration of cortisol (in both sexes) than corticosterone, then we would also expect the proportionate difference to be shared rather than preferentially biased towards the lower concentration glucocorticoid.
Therefore, we hypothesize that preferential corticosterone synthesis, seen in both sexes, will involve higher affinity of at least one shared steroidogenic enzyme for the corticosterone rather than cortisol substrate. In other words, preferential corticosterone synthesis would arise if a) the human fetal 11ß-hydroxylase enzyme affinity for 11-deoxycorticosterone is higher than its affinity for 11-deoxycortisol; b) the 11ß-HSD1 and 2 enzymes have higher affinity for dehydrogenation of cortisol than corticosterone; or c) the reductase role of the 11ß-HSD1 enzyme has preferentially higher affinity for cortisone than 11-dehydrocorticosterone, One or more of these affinities would result in proportionally higher (i.e. preferential) corticosterone synthesis.
If the enzyme-substrate affinities do not differ, then an alternate mechanism to generate the observed preferential synthesis of corticosterone would be lower binding affinity, or residence time, of corticosterone on corticosteroid binding globulin (CBG), or albumin, under competitive conditions where higher concentrations of cortisol are competing with the rarer corticosterone molecules for binding sites. Evidence that corticosteroid binding is dynamically regulated during pregnancy is widespread (Edwards and Boonstra, 2017) , and consistent with in (Jeffray et al., 1999) , and findings in pregnant women with genetic CBG deficiencies (Lei et al., 2015) .
The placenta expresses high levels of 11ß-HSD2 throughout gestation on the fetal side, and 11ß-HSD1 on the maternal side (Stirrat et al., 2018) . The fetus also has developmental changes at full-term in tissue 11ß-HSD1 reductase expression (Chapman et al 2013; Hirasawa et al 1999; Salvante et al 2017) , but sex differences have not been explored. Correlations were significant for cortisol and corticosterone as subject to the same synthesis and degradation enzymes, 11-hydroxyprogesterone and 11-deoxycortisol as sequential substrates on the pathway to cortisol, plus cortisone and 11-dehydrocorticosterone as the shared enzyme/ initial breakdown products of cortisol and corticosterone. However, although the female sample size was considerably smaller than the male sample size (20 vs 33), reducing statistical power, female associations between steroids were typically stronger, including correlations over 0.95 than male associations. This sex difference might reflect a developmental asynchrony between males and females at full term, particularly in light of the existing literature suggesting that placental steroidogenesis differs when the fetus is female (Clifton, 2010) .
Full-term maturation of fetal lungs and gross motor function also requires sufficient amniotic fluid (oligohydramnios is a recognized, serious, antenatal risk factor), and developmentally-appropriate kidney function. Thus, an alternative pathway to explain preferential corticosterone synthesis in the fetus is that an interaction with aldosterone synthesis and/or clearance is driving the preferential increase in arterial corticosterone pool size. Future research will be needed to identify the basis for preferential corticosterone secretion.
Different adrenal steroidogenic patterns in males and females
None of the hypotheses about mechanisms underlying preferential corticosterone
synthesis are able to explain the observed sex differences in the function of the adrenal steroid pathway. Simultaneous quantitation of 8 steroids, six of which were in the adrenal pathway, combined with paired arterial and venous samples, revealed an unanticipated sex difference.
Within males, each steroid changed significantly. Molarity for both products (cortisol and corticosterone) increased and all three substrates for cortisol synthesis (17-hydroxyprogesterone, 11-deoxycortisol and cortisone) decreased. With regards to corticosterone synthesis, 11-dehydrocorticosterone also decreased, but the two glucocorticoid pathways could not be directly compared because deoxycorticosterone and progesterone substrates were not quantified. When the fetus was male, the total molarity of steroid was so stable that the sum of individual concentration changes was not different from zero. Increases in cortisol were matched by equivalent molar depletions in cortisol substrate pools.
The situation differed considerably when the fetus was female. As noted above, increases in cortisol were even larger than those in males, with corticosterone also increasing. However, unlike the situation in males, there was little evidence of substrate depletion and no evidence of molar equivalency. Decreases in cortisone and 11-deoxycortisol and 17-hydroxyprogesterone and 11-dehydrocorticosterone substrates were not significantly different from zero. Thus, unlike the situation in the male, molar conversions do not explain the steroid pathway through which the female fetus adds an average of 65 nanomoles of new steroid to arterial umbilical cord circulation. Adrenal steroidogenic function differs depending on fetal sex.
The synthesis pathway from progesterone/ 17-hydroxyprogesterone to deoxycorticosterone/11-dexoycortisol, through the 21-hydroxylase enzyme, functioned similarly in each sex. Specifically, correlation between 17-hydroxyprogesterone and 11-deoxycortisol in arterial samples was notably high in males and in females, suggesting similar linkage activity of
the enzyme. Therefore, the most likely possibility is that the sexes differ in flux (rate of steroid conversion). A higher flux of steroid substrates from cholesterol all the way through to cortisol and corticosterone, would sustain net cortisol synthesis in the female without depleting substrate pools. The human fetus is more active in de novo conversion of acetate into cholesterol, and in the synthesis of 21-carbon progestagens and 19-carbon androgens from cholesterol, than the placenta (Pasqualini et al., 2016) . In other words, if female fetal steroidogenic enzymes are rapidly converting substrate to product, and that product is being rapidly converted to another product, static measures of substrate pool size (concentration) will not reveal that difference.
Nevertheless, it does represent a developmental sex difference in adrenal steroidogenesis.
Pregnancies with a male fetus are not the same as pregnancies with a female fetus (Clifton, 2010) .
Without data earlier in the pregnancy than full-term, and in the immediate postnatal window, the persistence of this sex difference is unknown. It is possible that this sex difference simply represents a developmental asynchrony in hypothalamic-pituitary-adrenal axis function between male and female. Further research will be necessary to clarify the temporal persistence of this sex difference during development.
Nevertheless, this clear sex difference in HPA axis function has the potential to play a significant role in establishing the early-life programming caused by stressors during early life that influence later life (Lorente-Pozo et al., 2018; Clifton, 2010) . Male birthweight was higher than female birthweight, and maternal salivary cortisol is linked to birthweight (Cherak et al 2018) . Male neonates also suffer more growth restriction from a repeated betamethasone treatment antenatally than females (Lorente-Pozo et al., 2018; Carson et al., 2016) , are more susceptible to hypoxic brain injury than females at birth (Fellman, 2015; Lehtonen et al., 2017) ,
and are more susceptible to intrauterine growth restriction, preterm delivery and stillbirth (Wilms et al., 2016) . Each of these risks increase in prevalence when there are maternal comorbidities such as severe asthma (Murphy et al., 2003) , pre-eclampsia (Stark et al., 2006; Stark et al., 2009b) , diabetes (Engel et al., 2008) , or exposure to environmental pollutants (Sakamoto et al., 2001) . It is therefore critical that antenatal sex differences in adrenal steroidogenesis pathway functioning are explored further. 
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